Latest filing published 04 Oct 2019 for IMV Inc. (formerly Immunovaccine Inc.), €3,825.
This profile gathers the share dealings of Andrew J. Sheldon in IMV Inc. (formerly Immunovaccine Inc.). Between 2 May 2018 and 3 October 2019, the trades on record add up to 23 filings.
No open-market sale appears; the market trades are 20 purchases worth €104k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2019: 8 purchases and no sales on the market.
The median purchase comes to €3,042. Across 20 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 4 October 2019 with an open-market purchase (€1,410) in IMV Inc. (formerly Immunovaccine Inc.). Publication is fast: at least half of the trades appear on SEDI on the same day. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations